Reportable Segments (Tables)

3 Months Ended

Mar. 31, 2014

Schedule of Segment Reporting Information, by Segment

The following table represents information for the Company’s reportable segments and its corporate function:



	Three Months Ended March 31,
	2014			2013
Sales
Energy & Chemicals	$	86,146		$	80,861
Distribution & Storage	129,522			128,733
BioMedical	50,572			64,054
Consolidated	$	266,240		$	273,648
Operating Income (Loss)
Energy & Chemicals	$	16,607		$	12,819
Distribution & Storage	18,087			19,289
BioMedical	2,395			6,753
Corporate	(14,943		)	(11,510		)
Consolidated	$	22,146		$	27,351

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References+ Details